BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr. Yuri Fesko has been appointed Chief Medical Officer of the company. In this new role, he will provide medical and clinical leadership across Quanterix, partnering closely with the company’s Diagnostics, Scientific, R&D, Regulatory, and […]

VIENNA — Cell-free DNA assembly pioneer, Ribbon Bio, has today announced the appointment of Jay Therrien as Chief Business Officer. Therrien joins Ribbon’s executive leadership team where he will lead the company’s commercial strategy and growth initiatives. Therrien brings over two decades of experience building and leading commercial organizations across the life sciences and genomics […]

SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company’s board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of service as a director. Koh joined Agilent’s board in 2003 and served as independent chair from 2017 until […]

Current Director Dr. Martin Madaus Appointed Interim CEO Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”) today announced that current member of the Board of Directors (the “Board”) Dr. Martin Madaus has been appointed interim President and CEO, and that John […]

Jon Pratt brings more than 25 years of leadership experience, most recently as CEO of Filtration Group and previously at Waters, Beckman Coulter Life Sciences and Pall To assume CEO role on September 1, 2026, succeeding Thierry Bernard QIAGEN reaffirms outlook for the third quarter and full-year 2026; strategic review continues VENLO, Netherlands —  QIAGEN […]

Appointments of Chief Development and Product Officer and Chief Marketing and Communications Officer Oxford Nanopore today announces the appointment of David Miller as Chief Development and Product Officer (CDPO) and Conor McKechnie as Chief Marketing and Communications Officer (CMCO), joining on 1st September and 1st October respectively. Together, these appointments strengthen the Oxford Nanopore’s leadership […]

Laboratory automation veteran brings nearly three decades of commercial and technical leadership to drive growth of Thomas Scientific’s technical sales organization SWEDESBORO, N.J. –  Thomas Scientific, a trusted distributor of laboratory supplies, equipment, and services, today announced that Jeff Hrush has joined the company as Senior Vice President, Technical Sales. Hrush brings nearly three decades […]

SAN JOSE, Calif. — Complete Genomics, a U.S.-based provider of end-to-end DNA sequencing platforms, reagents and software, today announced the appointment of entrepreneur, investor and film producer Lauren Selig to its board of directors. Selig is the founder of Shake and Bake Productions and leads an investment fund focused on companies across artificial intelligence, space, biotechnology, media and other […]

Veteran Pharmacogenomics Leader and Former St. Jude CEO to Guide BioSkryb’s Next Phase of Growth DURHAM, N.C. — BioSkryb Genomics, a pioneer in single-cell and ultra-low-input multiomic solutions, today announced that William E. Evans, Pharm.D., has been appointed as Chief Executive Officer. Dr. Evans has served on BioSkryb’s Board of Directors and as Chair of […]

Appointment strengthens Element’s board as the company continues to advance the future of precision medicine and AI-enabled drug discovery; executive promotions reflect growing maturity of the company SAN DIEGO, CA — Element Biosciences, Inc. today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors. Dr. Dolsten brings more than 35 years of leadership […]